Search

everythinglearnresearchcommunity

for

Search:↓

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Potential therapeutic targets for scarring hair loss are identified.

Increasing sebum production might help reduce fat and improve metabolism.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Immune cells affect hair growth and could lead to new hair loss treatments.

Hair loss treatment caused more hair loss in a man.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Alopecia areata involves immune response and gene changes affecting hair loss.

New psoriasis treatments are effective but come with side effects and risks.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.